These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30124008)

  • 1. Safety, Feasibility of Intravenous and Intrathecal Injection of Autologous Bone Marrow Derived Mesenchymal Stromal Cells in Patients with Amyotrophic Lateral Sclerosis: An Open Label Phase I Clinical Trial.
    Nabavi SM; Arab L; Jarooghi N; Bolurieh T; Abbasi F; Mardpour S; Azimyian V; Moeininia F; Maroufizadeh S; Sanjari L; Hosseini SE; Aghdami N
    Cell J; 2019 Jan; 20(4):592-598. PubMed ID: 30124008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosis.
    Oh KW; Moon C; Kim HY; Oh SI; Park J; Lee JH; Chang IY; Kim KS; Kim SH
    Stem Cells Transl Med; 2015 Jun; 4(6):590-7. PubMed ID: 25934946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Efficacy and Safety of Intrathecal Autologous Bone Marrow-Derived Mesenchymal Stromal Cells in Amyotrophic Lateral Sclerosis: A Pilot Study.
    Shamsaei G; Houshmand F; Ahmadzadeh Deylami A; Valizadeh A; Rafie S; Moradi M
    Adv Pharm Bull; 2023 Mar; 13(2):361-367. PubMed ID: 37342380
    [No Abstract]   [Full Text] [Related]  

  • 4. Transplantation of Mesenchymal Stromal Cells in Patients With Amyotrophic Lateral Sclerosis: Results of Phase I/IIa Clinical Trial.
    Syková E; Rychmach P; Drahorádová I; Konrádová Š; Růžičková K; Voříšek I; Forostyak S; Homola A; Bojar M
    Cell Transplant; 2017 Apr; 26(4):647-658. PubMed ID: 27938483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of bone marrow derived-mesenchymal stem cells transplantation in patients with amyotrophic lateral sclerosis.
    Tavakol-Afshari J; Boroumand AR; Farkhad NK; Adhami Moghadam A; Sahab-Negah S; Gorji A
    Regen Ther; 2021 Dec; 18():268-274. PubMed ID: 34466632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stromal Cells in Amyotrophic Lateral Sclerosis Patients, Single-Center, Prospective, Open-Label, Single-Arm Clinical Trial, Long-Term Follow-up.
    Nabavi SM; Karimi SH; Arab L; Sanjari L; Mardpour S; Azimian V; Jarughi N; Ghaheri A; Hosseini SE; Aghdami N; Vosough M
    Cell J; 2021 Dec; 23(7):772-778. PubMed ID: 34979067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis.
    Karussis D; Karageorgiou C; Vaknin-Dembinsky A; Gowda-Kurkalli B; Gomori JM; Kassis I; Bulte JW; Petrou P; Ben-Hur T; Abramsky O; Slavin S
    Arch Neurol; 2010 Oct; 67(10):1187-94. PubMed ID: 20937945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis: Results of Phase 1/2 and 2a Clinical Trials.
    Petrou P; Gothelf Y; Argov Z; Gotkine M; Levy YS; Kassis I; Vaknin-Dembinsky A; Ben-Hur T; Offen D; Abramsky O; Melamed E; Karussis D
    JAMA Neurol; 2016 Mar; 73(3):337-44. PubMed ID: 26751635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II clinical trial with repeated intrathecal injections of autologous mesenchymal stem cells in patients with amyotrophic lateral sclerosis.
    Petrou P; Kassis I; Yaghmour NE; Ginzberg A; Karussis D
    Front Biosci (Landmark Ed); 2021 Oct; 26(10):693-706. PubMed ID: 34719198
    [No Abstract]   [Full Text] [Related]  

  • 10. Biological markers of mesenchymal stromal cells as predictors of response to autologous stem cell transplantation in patients with amyotrophic lateral sclerosis: an investigator-initiated trial and in vivo study.
    Kim HY; Kim H; Oh KW; Oh SI; Koh SH; Baik W; Noh MY; Kim KS; Kim SH
    Stem Cells; 2014 Oct; 32(10):2724-31. PubMed ID: 24966156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of intrathecal autologous adipose-derived mesenchymal stromal cells in patients with ALS.
    Staff NP; Madigan NN; Morris J; Jentoft M; Sorenson EJ; Butler G; Gastineau D; Dietz A; Windebank AJ
    Neurology; 2016 Nov; 87(21):2230-2234. PubMed ID: 27784774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeat Administration of Bone Marrow-Derived Mesenchymal Stem Cells for Treatment of Amyotrophic Lateral Sclerosis.
    Siwek T; Jezierska-Woźniak K; Maksymowicz S; Barczewska M; Sowa M; Badowska W; Maksymowicz W
    Med Sci Monit; 2020 Dec; 26():e927484. PubMed ID: 33301428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotrophic bone marrow cellular nests prevent spinal motoneuron degeneration in amyotrophic lateral sclerosis patients: a pilot safety study.
    Blanquer M; Moraleda JM; Iniesta F; Gómez-Espuch J; Meca-Lallana J; Villaverde R; Pérez-Espejo MÁ; Ruíz-López FJ; García Santos JM; Bleda P; Izura V; Sáez M; De Mingo P; Vivancos L; Carles R; Jiménez J; Hernández J; Guardiola J; Del Rio ST; Antúnez C; De la Rosa P; Majado MJ; Sánchez-Salinas A; López J; Martínez-Lage JF; Martínez S
    Stem Cells; 2012 Jun; 30(6):1277-85. PubMed ID: 22415951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous bone marrow-derived stem cells in amyotrophic lateral sclerosis: a pilot study.
    Prabhakar S; Marwaha N; Lal V; Sharma RR; Rajan R; Khandelwal N
    Neurol India; 2012; 60(5):465-9. PubMed ID: 23135021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated Intrathecal Mesenchymal Stem Cells for Amyotrophic Lateral Sclerosis.
    Oh KW; Noh MY; Kwon MS; Kim HY; Oh SI; Park J; Kim HJ; Ki CS; Kim SH
    Ann Neurol; 2018 Sep; 84(3):361-373. PubMed ID: 30048006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of first-in-man intrathecal injection of human astrocytes (AstroRx®) in ALS patients: phase I/IIa clinical trial results.
    Gotkine M; Caraco Y; Lerner Y; Blotnick S; Wanounou M; Slutsky SG; Chebath J; Kuperstein G; Estrin E; Ben-Hur T; Hasson A; Molakandov K; Sonnenfeld T; Stark Y; Revel A; Revel M; Izrael M
    J Transl Med; 2023 Feb; 21(1):122. PubMed ID: 36788520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation, proof-of-concept, phase 1/2 study.
    Farge D; Loisel S; Resche-Rigon M; Lansiaux P; Colmegna I; Langlais D; Charles C; Pugnet G; Maria ATJ; Chatelus E; Martin T; Hachulla E; Kheav VD; Lambert NC; Wang H; Michonneau D; Martinaud C; Sensebé L; Cras A; Tarte K
    Lancet Rheumatol; 2022 Feb; 4(2):e91-e104. PubMed ID: 38288741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinal cord infusion of stem cells in amyotrophic lateral sclerosis: Magnetic resonance spectroscopy shows metabolite improvement in the precentral gyrus.
    García Santos JM; Inuggi A; Gómez Espuch J; Vázquez C; Iniesta F; Blanquer M; María Moraleda J; Martínez S
    Cytotherapy; 2016 Jun; 18(6):785-96. PubMed ID: 27173751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous transplantation of bone marrow-derived mesenchymal stromal cells in patients with multiple sclerosis, a phase I/IIa, double blind, randomized controlled study.
    Nabavi SM; Karimi S; Arab L; Aghdami N; Joghtaei N; Maroufizadeh S; Jarooghi N; Bolurieh T; Abbasi F; Mardpour S; Azimyian V; Moeininia F; Sanjari L; Hosseini SE; Vosough M
    Mult Scler Relat Disord; 2023 Oct; 78():104895. PubMed ID: 37515913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial.
    Mazzini L; Ferrero I; Luparello V; Rustichelli D; Gunetti M; Mareschi K; Testa L; Stecco A; Tarletti R; Miglioretti M; Fava E; Nasuelli N; Cisari C; Massara M; Vercelli R; Oggioni GD; Carriero A; Cantello R; Monaco F; Fagioli F
    Exp Neurol; 2010 May; 223(1):229-37. PubMed ID: 19682989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.